Avadel Pharmaceuticals PLC

At Avadel, we are committed to connecting the dots between sleep disorder care and the patient experience. With that, we are proud to sponsor the Narcolepsy Network Patient Experience and Program Study.     While we’ve made tremendous progress in recent years, there is still a lot of work to be done as a medical community. This survey is intended to better understand what is working well for people with narcolepsy and where there are gaps in care that need to be addressed.     Learn more about how the survey can inform important decisions that will influence the future of care: https://lnkd.in/eq2QZNbM  

Our CEO Greg Divis recently sat down with the St. Louis Post-Dispatch to discuss Avadel’s transformation over the past five years and how the company has evolved since he took the helm in 2019, including his vision to focus solely on sleep disorders, which resulted in Avadel reaching a significant milestone.     Read more from the interview here: https://lnkd.in/g_YmJKU7 

We’re proud to share that Avadel is set to join the Russell 3000®Index on Friday, June 28.    The annual reconstitution of the Russell 3000® Index measures the performance of the largest 3,000 U.S. companies.    Learn more: https://lnkd.in/gfmERPWB

Happy Pride Month from #TeamAvadel! At Avadel, we proudly celebrate the LGBTQ+ community. We remain committed to prioritizing a culture and work environment that fosters inclusivity and diversity where everyone feels secure and accepted for who they are. 

Today, as we commemorate #Juneteenth, we recognize the significance of this day in American history and affirm our commitment to diversity and inclusion – a fundamental part of who we are as a company and who we should be as a community.

Happy Father's Day to all the dads out there! #TeamAvadel proudly celebrates the remarkable fathers who uplift and inspire us. Here's to a day filled with well-deserved recognition. #FathersDay

Today, Avadel is participating in a fireside chat at the Goldman Sachs Healthcare Conference. Find details on our investor page. https://lnkd.in/d6SJgp_t 

#TeamAvadel had an incredible time at #SLEEP2024 in Houston, Texas, joining leaders within the sleep and narcolepsy space to reaffirm our commitment to supporting those within the community.    Thank you to American Academy of Sleep Medicine and Sleep Research Society for hosting another great conference. We’ll see you at #SLEEP2025! https://www.avadel.com/

Today, Avadel is participating in a fireside chat at the Jeffries Healthcare Conference. Find details on our investor page.  https://lnkd.in/d6SJgp_t

During Idiopathic Hypersomnia Awareness Week, we’re excited not only to show our support of the IH community, but also to share that our Phase 3 REVITALYZ clinical trial for IH will be enrolling patients in the second half of this year.    We’ll be updating our page, www.revitalyz.com, this summer with study details and clinical sites for people with IH and their supporters who want to learn more. https://www.revitalyz.com/